Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2

被引:20
作者
Yuan, Meng [1 ]
Wang, Yiquan [2 ]
Lv, Huibin [2 ,3 ]
Tan, Timothy J. C. [4 ]
Wilson, Ian A. [1 ,5 ]
Wu, Nicholas C. [2 ,4 ,6 ,7 ]
机构
[1] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
[2] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
[3] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China
[4] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA
[5] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[6] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA
[7] Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61801 USA
基金
美国国家卫生研究院;
关键词
allelic preference; broadly neutralizing; COVID-19; CP: Immunology; CP: Microbiology; data mining; public antibody; SARS-CoV-2; sequence analysis; variants of concern;
D O I
10.1016/j.celrep.2022.111650
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concerns (VOCs) continue to emerge, cross-neutralizing antibody responses become key toward next-generation design of amore universal COVID-19 vaccine. By analyzing published data from the literature, we report here that the combination of germline genes IGHV2-5/IGLV2-14 represents a public antibody response to the receptor-binding domain (RBD) that potently cross-neutralizes a broad range of VOCs, including Omicron and its sub-lineages. Detailed molecular analysis shows that the complementarity-determining region H3 sequences of IGHV2-5/IGLV2-14-encoded RBD antibodies have a preferred length of 11 amino acids and a conserved HxIxxI motif. In addition, these antibodies have a strong allelic preference due to an allelic polymorphism at amino acid residue 54 of IGHV2-5, which is located at the paratope. These findings have important implications for understanding cross-neutralizing antibody responses to SARS-CoV-2 and its heterogenicity at the population level as well as the development of a universal COVID-19 vaccine.
引用
收藏
页数:10
相关论文
共 51 条
[31]  
Raybould Matthew I J, 2021, Bioinformatics, V37, P734, DOI 10.1093/bioinformatics/btaa739
[32]   SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies [J].
Reincke, S. Momsen ;
Yuan, Meng ;
Kornau, Hans-Christian ;
Corman, Victor M. ;
van Hoof, Scott ;
Sanchez-Sendin, Elisa ;
Ramberger, Melanie ;
Yu, Wenli ;
Hua, Yuanzi ;
Tien, Henry ;
Schmidt, Marie Luisa ;
Schwarz, Tatjana ;
Jeworowski, Lara Maria ;
Brandl, Sarah E. ;
Rasmussen, Helle Foverskov ;
Homeyer, Marie A. ;
Stoffler, Laura ;
Barner, Martin ;
Kunkel, Desiree ;
Huo, Shufan ;
Horler, Johannes ;
von Wardenburg, Niels ;
Kroidl, Inge ;
Eser, Tabea M. ;
Wieser, Andreas ;
Geldmacher, Christof ;
Hoelscher, Michael ;
Ganzer, Hannes ;
Weiss, Gunter ;
Schmitz, Dietmar ;
Drosten, Christian ;
Pruss, Harald ;
Wilson, Ian A. ;
Kreye, Jakob .
SCIENCE, 2022, 375 (6582) :782-+
[33]  
Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]
[34]  
Rodrigues Joao P G L M, 2018, F1000Res, V7, P1961, DOI 10.12688/f1000research.17456.1
[35]   High frequency of shared clonotypes in human B cell receptor repertoires [J].
Soto, Cinque ;
Bombardi, Robin G. ;
Branchizio, Andre ;
Kose, Nurgun ;
Matta, Pranathi ;
Sevy, Alexander M. ;
Sinkovits, Robert S. ;
Gilchuk, Pavlo ;
Finn, Jessica A. ;
Crowe, James E., Jr. .
NATURE, 2019, 566 (7744) :398-+
[36]   SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape [J].
Starr, Tyler N. ;
Czudnochowski, Nadine ;
Liu, Zhuoming ;
Zatta, Fabrizia ;
Park, Young-Jun ;
Addetia, Amin ;
Pinto, Dora ;
Beltramello, Martina ;
Hernandez, Patrick ;
Greaney, Allison J. ;
Marzi, Roberta ;
Glass, William G. ;
Zhang, Ivy ;
Dingens, Adam S. ;
Bowen, John E. ;
Tortorici, M. Alejandra ;
Walls, Alexandra C. ;
Wojcechowskyj, Jason A. ;
De Marco, Anna ;
Rosen, Laura E. ;
Zhou, Jiayi ;
Montiel-Ruiz, Martin ;
Kaiser, Hannah ;
Dillen, Josh R. ;
Tucker, Heather ;
Bassi, Jessica ;
Silacci-Fregni, Chiara ;
Housley, Michael P. ;
di Iulio, Julia ;
Lombardo, Gloria ;
Agostini, Maria ;
Sprugasci, Nicole ;
Culap, Katja ;
Jaconi, Stefano ;
Meury, Marcel ;
Dellota Jr, Exequiel ;
Abdelnabi, Rana ;
Foo, Shi-Yan Caroline ;
Cameroni, Elisabetta ;
Stumpf, Spencer ;
Croll, Tristan I. ;
Nix, Jay C. ;
Havenar-Daughton, Colin ;
Piccoli, Luca ;
Benigni, Fabio ;
Neyts, Johan ;
Telenti, Amalio ;
Lempp, Florian A. ;
Pizzuto, Matteo S. ;
Chodera, John D. .
NATURE, 2021, 597 (7874) :97-+
[37]   Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms [J].
Tortorici, M. Alejandra ;
Beltramello, Martina ;
Lempp, Florian A. ;
Pinto, Dora ;
Dang, Ha, V ;
Rosen, Laura E. ;
McCallum, Matthew ;
Bowen, John ;
Minola, Andrea ;
Jaconi, Stefano ;
Zatta, Fabrizia ;
De Marco, Anna ;
Guarino, Barbara ;
Bianchi, Siro ;
Lauron, Elvin J. ;
Tucker, Heather ;
Zhou, Jiayi ;
Peter, Alessia ;
Havenar-Daughton, Colin ;
Wojcechowskyj, Jason A. ;
Case, James Brett ;
Chen, Rita E. ;
Kaiser, Hannah ;
Montiel-Ruiz, Martin ;
Meury, Marcel ;
Czudnochowski, Nadine ;
Spreafico, Roberto ;
Dillen, Josh ;
Ng, Cindy ;
Sprugasci, Nicole ;
Culap, Katja ;
Benigni, Fabio ;
Abdelnabi, Rana ;
Foo, Shi-Yan Caroline ;
Schmid, Michael A. ;
Cameroni, Elisabetta ;
Riva, Agostino ;
Gabrieli, Arianna ;
Galli, Massimo ;
Pizzuto, Matteo S. ;
Neyts, Johan ;
Diamond, Michael S. ;
Virgin, Herbert W. ;
Snell, Gyorgy ;
Corti, Davide ;
Fink, Katja ;
Veesler, David .
SCIENCE, 2020, 370 (6519) :950-+
[38]   Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants [J].
Wang, Kang ;
Jia, Zijing ;
Bao, Linilin ;
Wang, Lei ;
Cao, Lei ;
Chi, Hang ;
Hu, Yaling ;
Li, Qianqian ;
Zhou, Yunjiao ;
Jiang, Yinan ;
Zhu, Qianhui ;
Deng, Yongqiang ;
Liu, Pan ;
Wang, Nan ;
Wang, Lin ;
Liu, Min ;
Li, Yurong ;
Zhu, Boling ;
Fan, Kaiyue ;
Fu, Wangjun ;
Yang, Peng ;
Pei, Xinran ;
Cui, Zhen ;
Qin, Lili ;
Ge, Pingju ;
Wu, Jiajing ;
Liu, Shuo ;
Chen, Yiding ;
Huang, Weijin ;
Wang, Qiao ;
Qin, Cheng-Feng ;
Wang, Youchun ;
Qin, Chuan ;
Wang, Xiangxi .
NATURE, 2022, 603 (7903) :919-+
[39]   Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants [J].
Wang, Lingshu ;
Zhou, Tongqing ;
Zhang, Yi ;
Yang, Eun Sung ;
Schramm, Chaim A. ;
Shi, Wei ;
Pegu, Amarendra ;
Oloniniyi, Olamide K. ;
Henry, Amy R. ;
Darko, Samuel ;
Narpala, Sandeep R. ;
Hatcher, Christian ;
Martinez, David R. ;
Tsybovsky, Yaroslav ;
Phung, Emily ;
Abiona, Olubukola M. ;
Antia, Avan ;
Cale, Evan M. ;
Chang, Lauren A. ;
Choe, Misook ;
Corbett, Kizzmekia S. ;
Davis, Rachel L. ;
DiPiazza, Anthony T. ;
Gordon, Ingelise J. ;
Helmold-Hait, Sabrina ;
Hermanus, Tandile ;
Kgagudi, Prudence ;
Laboune, Farida ;
Leung, Kwanyee ;
Liu, Tracy ;
Mason, Rosemarie D. ;
Nazzari, Alexandra F. ;
Novik, Laura ;
O'Connell, Sarah ;
O'Dell, Sijy ;
Olia, Adam S. ;
Schmidt, Stephen D. ;
Stephens, Tyler ;
Stringham, Christopher D. ;
Talana, Chloe Adrienna ;
Teng, I-Ting ;
Wagner, Danielle A. ;
Widge, Alicia T. ;
Zhang, Baoshan ;
Roederer, Mario ;
Ledgerwood, Julie E. ;
Ruckwardt, Tracy J. ;
Gaudinski, Martin R. ;
Moore, Penny L. ;
Doria-Rose, Nicole A. .
SCIENCE, 2021, 373 (6556) :759-+
[40]   A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2 [J].
Wang, Yiquan ;
Yuan, Meng ;
Lv, Huibin ;
Peng, Jian ;
Wilson, Ian A. ;
Wu, Nicholas C. .
IMMUNITY, 2022, 55 (06) :1105-+